LIGAND PHARMACEUTICALS INC【LGND】Balance sheet

Market cap

$3.9B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	7	12	12	160	97	19	21	120	72	48	20	45	23	72
Marketable securities, current	10	-	4	7	103	122	181	601	998	364	322	167	147	184
Total cash & short-term investments	17	12	16	167	200	141	202	721	1,071	412	341	212	170	256
Accounts receivable, net	-	-	-	-	-	-	-	-	30	57	85	30	33	38
Inventories	1	2	1	0	2	2	4	7	7	26	27	13	24	14
Total current assets	32	24	25	185	216	163	237	871	1,124	501	465	264	237	332
Property, plant and equipment, net	0	1	1	0	0	2	4	5	7	14	21	12	16	15
Total non-current assets	90	80	80	73	318	439	434	390	371	862	833	499	550	610
Total assets	122	104	105	258	534	602	671	1,261	1,495	1,362	1,298	763	787	942
Accounts payable	11	6	4	8	4	3	2	4	2	4	8	5	2	5
Total current liabilities	44	35	29	23	21	227	239	82	17	100	42	99	17	37
Total non-current liabilities	62	42	26	211	209	4	14	618	711	553	435	66	70	74
Total liabilities	105	78	55	234	230	231	252	700	728	653	476	165	86	111
Common stock and paid-in capital	733	752	718	681	662	770	798	791	367	318	373	148	199	337
Retained earnings	-682	-683	-671	-659	-402	-431	-401	-229	400	392	449	451	503	499
Stockholders' equity	-	26	50	26	304	341	400	561	767	710	821	597	701	830
Working capital	-	-	-	-	-	-	-	-